Molly L Nozyce
Overview
Explore the profile of Molly L Nozyce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sirois P, Huo Y, Nozyce M, Garvie P, Harris L, Malee K, et al.
J Int AIDS Soc
. 2022 Sep;
25 Suppl 4:e25982.
PMID: 36176020
Introduction: Medical challenges, including perinatally acquired HIV (PHIV), can be considered adversity with the potential to compromise individuals' ability to meet societal expectations across the lifespan. Studies suggest that resilience,...
2.
Malee K, Chernoff M, Sirois P, Williams P, Garvie P, Kammerer B, et al.
J Acquir Immune Defic Syndr
. 2017 May;
75(4):455-464.
PMID: 28481783
Background: Little is known regarding effects of perinatally acquired HIV infection (PHIV) on longitudinal change in memory and executive functioning (EF) during adolescence despite the importance of these skills for...
3.
Sirois P, Chernoff M, Malee K, Garvie P, Harris L, Williams P, et al.
J Pediatric Infect Dis Soc
. 2016 Nov;
5(suppl 1):S24-S32.
PMID: 27856673
Background: Perinatally acquired HIV (PHIV) confers risk for neurocognitive impairment, which potentially affects school performance and functional independence of infected children. In this study, we examined the associations of 2...
4.
Sirois P, Aaron L, Montepiedra G, Pearson D, Kapetanovic S, Williams P, et al.
Pediatr Infect Dis J
. 2016 Jan;
35(1):e12-8.
PMID: 26741589
Background: Limited empirical investigation exists into longitudinal changes in cognition, behavior or quality of life (QOL) in children with perinatal HIV who are prescribed stimulants. Methods: This study was an...
5.
Nozyce M, Huo Y, Williams P, Kapetanovic S, Hazra R, Nichols S, et al.
Pediatr Infect Dis J
. 2014 Nov;
33(11):1128-33.
PMID: 25361407
Background: Long-term effects of in utero and neonatal antiretroviral (ARV) exposure on cognitive and academic development in HIV-exposed, uninfected school-age children are unknown. Methods: HIV-exposed, uninfected children, ages 5-13 years,...
6.
Sirois P, Huo Y, Williams P, Malee K, Garvie P, Kammerer B, et al.
Pediatr Infect Dis J
. 2013 Jan;
32(6):648-55.
PMID: 23340561
Background: This study evaluated effects of perinatal exposure to antiretroviral (ARV) medications on neurodevelopment of HIV-exposed, uninfected infants. Methods: HIV-exposed, uninfected infants (age 9-15 months) enrolled in Surveillance Monitoring for...
7.
Kapetanovic S, Aaron L, Montepiedra G, Sirois P, Oleske J, Malee K, et al.
AIDS Patient Care STDS
. 2009 Oct;
23(11):939-47.
PMID: 19827949
Second-generation antipsychotics (SGAs) are increasingly prescribed to treat psychiatric symptoms in pediatric patients infected with HIV. We examined the relationship between prescribed SGAs and physical growth in a cohort of...
8.
Sirois P, Montepiedra G, Kapetanovic S, Williams P, Pearson D, Malee K, et al.
J Dev Behav Pediatr
. 2009 Oct;
30(5):403-12.
PMID: 19827220
Objective: To examine the relationships between physical growth and medications prescribed for symptoms of attention-deficit hyperactivity disorder in children with HIV. Methods: Analysis of data from children with perinatally acquired...
9.
Nozyce M, Lee S, Wiznia A, Nachman S, Mofenson L, Smith M, et al.
Pediatrics
. 2006 Mar;
117(3):763-70.
PMID: 16510656
Objective: The purpose of this research was to characterize behavioral and cognitive profiles of clinically and immunologically stable antiretroviral-experienced HIV-infected children. Methods: Two hundred seventy-four previously treated HIV-infected children aged...